We are live on ! Find out more
Nuveen

Nuveen Portfolio holdings

AUM $419B
1-Year Est. Return 43.02%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+43.02%
3 Year Est. Return
+139.43%
5 Year Est. Return
+185.66%
10 Year Est. Return
+615.13%
AUM
$264B
AUM Growth
+$16.6B
Cap. Flow
-$3.77B
Cap. Flow %
-1.43%
Top 10 Hldgs %
18.75%
Holding
3,331
New
118
Increased
1,090
Reduced
1,840
Closed
95

Top Sells

Rank Stock Value
1
CSCO icon
Cisco
CSCO
+$474M
2
CELG
Celgene Corp
CELG
+$421M
3
AVGO icon
Broadcom
AVGO
+$411M
4
NFLX icon
Netflix
NFLX
+$387M
5
AAPL icon
Apple
AAPL
+$372M

Sector Composition

Rank Sector Weight
1 Technology 20.7%
2 Financials 14.71%
3 Healthcare 13.49%
4 Consumer Discretionary 10.31%
5 Communication Services 9.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SGC icon
2926
Superior Group of Companies
SGC
$205M
$449K ﹤0.01%
33,128
-966
-3% -$13.9K
MQT
2927
DELISTED
BlackRock MuniYield Quality Fund II
MQT
$446K ﹤0.01%
34,321
– –
NATH icon
2928
Nathan's Famous
NATH
$416M
$441K ﹤0.01%
6,224
-4,809
-44% -$354K
MAV
2929
DELISTED
Pioneer Municipal High Income Advantage Fund
MAV
$440K ﹤0.01%
40,709
– –
HESM icon
2930
Hess Midstream
HESM
$4.91B
$439K ﹤0.01%
19,376
-2,113
-10% -$44.2K
SENS icon
2931
Senseonics Holdings Inc
SENS
$529M
$439K ﹤0.01%
23,972
-23,896
-50% -$471K
FFNW
2932
DELISTED
First Financial Northwest, Inc
FFNW
$439K ﹤0.01%
29,396
– –
LCTX icon
2933
Lineage Cell Therapeutics
LCTX
$260M
$435K ﹤0.01%
489,811
-580,940
-54% -$484K
USX
2934
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$435K ﹤0.01%
86,434
-1,442
-2% -$7.02K
RRBI icon
2935
Red River Bancshares
RRBI
$665M
$434K ﹤0.01%
+7,748
New +$369K
LITS
2936
Lite Strategy Inc
LITS
$49M
$430K ﹤0.01%
8,676
-86
-1% -$3.2K
NC icon
2937
NACCO Industries
NC
$284M
$428K ﹤0.01%
9,129
-15,271
-63% -$811K
PRTK
2938
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$428K ﹤0.01%
106,199
-14,675
-12% -$50.9K
GCAP
2939
DELISTED
Gain Capital Holdings, Inc.
GCAP
$428K ﹤0.01%
108,264
– –
CTSO icon
2940
Cytosorbents Corp
CTSO
$13.8M
$425K ﹤0.01%
5,520
– –
EVBN
2941
DELISTED
Evans Bancorp Inc
EVBN
$423K ﹤0.01%
10,546
-8,015
-43% -$312K
SLCT
2942
DELISTED
Select Bancorp, Inc.
SLCT
$423K ﹤0.01%
34,433
-5,128
-13% -$60.3K
ODC icon
2943
Oil-Dri
ODC
$1.28B
$415K ﹤0.01%
22,906
-18,860
-45% -$331K
AMSC icon
2944
American Superconductor
AMSC
$1.45B
$409K ﹤0.01%
52,122
-486
-0.9% -$3.92K
IQI icon
2945
Invesco Quality Municipal Securities
IQI
$473M
$409K ﹤0.01%
32,524
– –
KNSA icon
2946
Kiniksa Pharmaceuticals
KNSA
$5.86B
$409K ﹤0.01%
36,970
-3,770
-9% -$32.8K
TWIN icon
2947
Twin Disc
TWIN
$380M
$409K ﹤0.01%
37,052
-526
-1% -$5.5K
CFFI icon
2948
C&F Financial
CFFI
$304M
$406K ﹤0.01%
7,344
-5,997
-45% -$320K
PTN
2949
Palatin Technologies
PTN
$18M
$404K ﹤0.01%
414
– –
DLTH icon
2950
Duluth Holdings
DLTH
$151M
$397K ﹤0.01%
37,667
– –

Similar funds

Nuveen's Q4 2019 Portfolio in Review

As of Q4 2019, Nuveen held 3,331 positions worth $264B, up 6.7% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Nuveen's Q4 2019 filing shows 118 new, 1,090 increased, 1,840 reduced and 95 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B. The largest sale was Cisco, an estimated $474M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Nuveen's largest Q4 2019 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B.
  • Nuveen added most to Bristol-Myers Squibb in Q4 2019, an estimated $649M increase.
  • Nuveen's biggest Q4 2019 reduction was Cisco, cutting an estimated $474M.
  • Nuveen fully exited Celgene Corp in Q4 2019, selling an estimated $421M.
  • Nuveen's ten largest holdings make up 19% of its $264B portfolio in Q4 2019.
  • Nuveen opened 118 new positions and closed 95 in Q4 2019.
  • Nuveen's portfolio value rose 6.7% quarter-over-quarter to $264B.

Based on Nuveen's 13F filing for Q4 2019, filed 14 Feb 2020.